Related Experiment Video
Updated: Jul 31, 2025

Technical Detail for Robot Assisted Pancreaticoduodenectomy
Published on: September 28, 2019
Survival, hospitalisation and surgery in children born with Pierre Robin sequence: a European population-based cohort
Michele Santoro1, Ester Garne2, Alessio Coi3
1Unit of Epidemiology of rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy msantoro@ifc.cnr.it.
Insights
Children with Pierre Robin sequence (PRS) have high early mortality and morbidity, with most requiring surgery before age five. Survival rates improve after infancy, with fewer hospitalizations noted between ages five and nine.
Area of Science:
- Pediatric Health
- Congenital Anomalies
- Public Health Surveillance
Background:
- Pierre Robin sequence (PRS) is a congenital condition affecting craniofacial development.
- Understanding the long-term outcomes of PRS is crucial for patient care and resource allocation.
Purpose of the Study:
- To evaluate survival rates, hospitalization patterns, and surgical interventions in children with PRS across Europe.
- To provide reliable data for families and healthcare providers managing PRS.
Main Methods:
- A multicentre, population-based cohort study utilizing data from 12 EUROCAT congenital anomaly registries.
- Electronic linkage of PRS birth data (1995-2014) with mortality, hospitalization, and surgical procedure data up to 10 years of age.
- Standardized data analysis using common data models and pooled results via random-effect meta-analyses.
Main Results:
- Survival to age 10 was 95.1%. The majority of deaths occurred within the first year of life.
- Nearly all children (99.2%) were hospitalized in the first year, with a median stay of 21.4 days; 67.6% underwent surgery.
- By age five, 99.2% had undergone a median of two surgeries. Hospitalizations decreased after age five.
Conclusions:
- Children with PRS experience significant early-life morbidity, including high rates of hospitalization and surgery.
- Survival improves post-infancy, with a notable reduction in hospitalizations after age five.
- This study offers essential, reliable estimates on PRS survival and morbidity for clinical and familial guidance.
Objective:
To evaluate survival, hospitalisations and surgical procedures for children born with Pierre Robin sequence (PRS) across Europe.
Design:
Multicentre population-based cohort study.
Setting:
Data on 463 live births with PRS from a population of 4 984 793 from 12 EUROCAT congenital anomaly registries.
Methods:
Data on children with PRS born 1995-2014 were linked electronically to data on mortality, hospitalisations and surgical procedures up to 10 years of age. Each registry applied a common data model to standardise the linked data and ran common syntax scripts to produce aggregate tables. Results from each registry were pooled using random-effect meta-analyses.
Main Outcome Measures:
Probability of survival, proportion of children hospitalised and undergoing surgery, and median length of hospital stay.
Results:
The majority of deaths occurred in the first year of life with a survival rate of 96.0% (95% CI 93.5% to 98.5%); 95.1% (95% CI 92.7% to 97.7%) survived to age 10. In the first year of life, 99.2% (95% CI 95.0% to 99.9%) of children were hospitalised with a median stay of 21.4 days (95% CI 15.6 to 27.2), and 67.6% (95% CI 46.6% to 81.8%) underwent surgery. In the first 5 years of life, 99.2% of children underwent a median of two surgical procedures. Between ages 5 and 9, 58.3% (95% CI 44.7% to 69.7%) were hospitalised with a median annual stay of 0.3 days.
Conclusions:
Children with PRS had high mortality and morbidity with long hospital stays in the first year of life, and almost all had surgery before 5 years of age. Survival improved after infancy with fewer hospitalisations after age 5. This study provides reliable estimates of the survival and morbidity of children with PRS for families and healthcare providers.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Assumptions of Survival Analysis
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

